Literature DB >> 17502228

Diagnosis and management of acute HIV infection.

Nicola M Zetola1, Christopher D Pilcher.   

Abstract

HIV infection starts as an acute, systemic infection, followed by a chronic period of clinical latency, usually lasting 3 to 10 years, which precedes the eventual collapse of the immune system. It is increasingly recognized that events occurring during acute HIV infection may determine the natural course of the disease. The very dynamic events of acute HIV infection provide multiple opportunities for biologic interventions, such as anti-retroviral or immune-based therapies. Similarly, the implementation of public health measures during acute HIV infection could help control epidemics or outbreaks. Many of the dramatic possibilities for intervention in acute HIV infection remain unproved, not the least because of traditional difficulty of diagnosing patients during this early period. This article reviews the natural history, pathogenesis and clinical presentation of acute HIV infection, and suggests a diagnostic and therapeutic approach to guide clinicians dealing with patients with suspected or confirmed acute HIV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502228     DOI: 10.1016/j.idc.2007.01.008

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  38 in total

1.  Integrating acute HIV infection within routine public health surveillance practices in New York City.

Authors:  Sara Bodach; Sarah Braunstein; Marie Antoinette Bernard; Charulata Jain Sabharwal; Adey Tsega; Colin Shepard
Journal:  Public Health Rep       Date:  2012 Jul-Aug       Impact factor: 2.792

2.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

3.  Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.

Authors:  Andrew C Young; Constantin T Yiannoutsos; Manu Hegde; Evelyn Lee; Julia Peterson; Rudy Walter; Richard W Price; Dieter J Meyerhoff; Serena Spudich
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

4.  Acute HIV infection transmission among people who inject drugs in a mature epidemic setting.

Authors:  Daniel J Escudero; Mark N Lurie; Kenneth H Mayer; Caleb Weinreb; Maximilian King; Sandro Galea; Samuel R Friedman; Brandon D L Marshall
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

5.  HIV & Hepatitis in the Americas 28-30 April 2016, Mexico City, Mexico.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-04-28       Impact factor: 5.396

6.  Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.

Authors:  Erica Weber; Erin E Morgan; Jennifer E Iudicello; Kaitlin Blackstone; Igor Grant; Ronald J Ellis; Scott L Letendre; Susan Little; Sheldon Morris; Davey M Smith; David J Moore; Steven Paul Woods
Journal:  J Neurovirol       Date:  2012-12-19       Impact factor: 2.643

7.  Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.

Authors:  Gretja Schnell; Richard W Price; Ronald Swanstrom; Serena Spudich
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

8.  Detection of HIV-1 in alternative specimen types using the APTIMA HIV-1 RNA Qualitative Assay.

Authors:  C Thomas Nugent; J Dockter; F Bernardin; R Hecht; D Smith; E Delwart; C Pilcher; D Richman; M Busch; C Giachetti
Journal:  J Virol Methods       Date:  2009-02-24       Impact factor: 2.014

9.  The failure of routine rapid HIV testing: a case study of improving low sensitivity in the field.

Authors:  Benjamin J Wolpaw; Catherine Mathews; Mickey Chopra; Diana Hardie; Virginia de Azevedo; Karen Jennings; Mark N Lurie
Journal:  BMC Health Serv Res       Date:  2010-03-22       Impact factor: 2.655

10.  Transmitted HIV drug resistance in treatment-naive Romanian patients.

Authors:  Aura Temereanca; Luminita Ene; Sanjay Mehta; Loredana Manolescu; Dan Duiculescu; Simona Ruta
Journal:  J Med Virol       Date:  2013-04-16       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.